In a patient with impaired renal function and an LDL cholesterol of 135 mg/dL and HDL cholesterol of 37 mg/dL, should a statin be started?

Yes, Start a Statin in This Patient with Low Kidney Function

In a patient with impaired renal function, an LDL of 135 mg/dL and HDL of 37 mg/dL, you should initiate statin therapy. This patient has chronic kidney disease (CKD), which is classified as a high or very high cardiovascular risk condition regardless of lipid levels 1, 2.

Why CKD Changes the Decision

CKD itself is a "risk-enhancing factor" that justifies statin therapy independent of specific LDL thresholds 1. The 2019 AHA/ACC guidelines explicitly state that in adults 40-75 years with LDL 70-189 mg/dL and 10-year ASCVD risk ≥7.5%, CKD not on dialysis is a risk-enhancing factor favoring moderate-intensity statin initiation 1.

The European guidelines are even more direct: patients with stage 3-5 CKD must be considered at high or very high cardiovascular risk, and statins or statin/ezetimibe combination is indicated in non-dialysis-dependent CKD 2. This is a Class I, Level A recommendation—the strongest evidence grade.

The Low HDL Adds Further Risk

Your patient's HDL of 37 mg/dL (below the 40 mg/dL threshold for men) represents an additional cardiovascular risk factor 3. Combined with CKD, this creates a compounding risk profile that further supports statin initiation.

Practical Treatment Approach

For Non-Dialysis CKD (eGFR <60 but not on dialysis):

• Start with moderate-intensity statin as first-line 1
• Alternatively, consider moderate-intensity statin plus ezetimibe 1
• The KDIGO approach recommends using regimens proven in CKD trials rather than treating to specific LDL targets 4

Specific Dosing Considerations:

For patients with eGFR <60 mL/min/1.73 m², consider these moderate-intensity options 5:

• Atorvastatin 20 mg
• Rosuvastatin 10 mg
• Pravastatin 40 mg
• Simvastatin 40 mg (avoid 80 mg dose)

No dose adjustment is required for atorvastatin in kidney disease; rosuvastatin doesn't require adjustment until creatinine clearance <30 mL/min/1.73 m² 5.

Important Caveats

The Dialysis Exception:

If this patient is already on dialysis, do NOT initiate a statin 1, 2. This is a Class III recommendation (no benefit) based on large RCTs showing no mortality benefit in dialysis patients 1. However, if the patient was already taking a statin before starting dialysis, it may be reasonable to continue it 1.

Don't Treat to Target:

Unlike general population guidelines, you do not need to titrate the statin dose to achieve specific LDL targets in CKD patients 4. The "fire-and-forget" strategy using proven moderate-intensity regimens is preferred, as it reduces unnecessary testing, avoids high-dose statin toxicity risks, and simplifies management 4.

The Evidence Hierarchy

The strongest evidence comes from:

1. 2019 AHA/ACC guidelines 1 - most recent major US guideline
2. 2016 ESC/EAS guidelines 2 - Class I, Level A recommendation for CKD
3. 2013 KDIGO guidelines 5, 4 - CKD-specific recommendations

All converge on the same conclusion: CKD patients not on dialysis should receive statins for cardiovascular risk reduction, with the decision driven by CKD status itself rather than specific LDL cutoffs 6, 7.